Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline. 2016

Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.

Low insulin-like growth factor-1 (IGF-1) signaling is associated with improved longevity, but is paradoxically linked with several age-related diseases in humans. Insulin-like growth factor-1 has proven to be particularly beneficial to the brain, where it confers protection against features of neuronal and cognitive decline. While aging is characterized by central insulin resistance in the face of hyperinsulinemia, the somatotropic axis markedly declines in older humans. Thus, we hypothesized that increasing IGF-1 in the brain may prove to be a novel therapeutic alternative to overcome central insulin resistance and restore whole-body insulin action in aging. Utilizing hyperinsulinemic-euglycemic clamps, we show that old insulin-resistant rats with age-related declines in IGF-1 level demonstrate markedly improved whole-body insulin action, when treated with central IGF-1, as compared to central vehicle or insulin (P < 0.05). Furthermore, central IGF-1, but not insulin, suppressed hepatic glucose production and increased glucose disposal rates in aging rats (P < 0.05). Taken together, IGF-1 action in the brain and periphery provides a 'balance' between its beneficial and detrimental actions. Therefore, we propose that strategies aimed at 'tipping the balance' of IGF-1 action centrally are the optimal approach to achieve healthy aging and longevity in humans.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015309 Glucose Clamp Technique Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration. Euglycemic Clamping,Glucose Clamping,Euglycaemic Clamp,Euglycaemic Clamping,Euglycemic Clamp,Glucose Clamp,Glucose Clamp Technic,Clamp, Euglycaemic,Clamp, Euglycemic,Clamp, Glucose,Clamping, Euglycaemic,Clamping, Euglycemic,Clamping, Glucose,Clamps, Euglycaemic,Clamps, Euglycemic,Clamps, Glucose,Euglycaemic Clamps,Euglycemic Clamps,Glucose Clamp Technics,Glucose Clamp Techniques,Glucose Clamps,Technic, Glucose Clamp,Technics, Glucose Clamp,Technique, Glucose Clamp,Techniques, Glucose Clamp

Related Publications

Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
October 2001, Molecular pathology : MP,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
May 2023, Pharmaceuticals (Basel, Switzerland),
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
March 2018, Ageing research reviews,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
January 2015, Pediatric endocrinology, diabetes, and metabolism,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
February 2005, Endocrine journal,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
June 2014, The aging male : the official journal of the International Society for the Study of the Aging Male,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
August 1991, Burns : journal of the International Society for Burn Injuries,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
June 2002, The Journal of clinical endocrinology and metabolism,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
April 2000, The Journal of clinical endocrinology and metabolism,
Derek M Huffman, and Gabriela Farias Quipildor, and Kai Mao, and Xueying Zhang, and Junxiang Wan, and Pasha Apontes, and Pinchas Cohen, and Nir Barzilai
January 2003, Neurobiology of aging,
Copied contents to your clipboard!